# Study of Picoplatin Efficacy After Relapse

> **NCT00465491** · PHASE3 · UNKNOWN · sponsor: **Poniard Pharmaceuticals** · enrollment: 399 (estimated)

## Conditions studied

- Small Cell Lung Cancer

## Interventions

- **DRUG:** picoplatin
- **OTHER:** best supportive care

## Key facts

- **NCT ID:** NCT00465491
- **Lead sponsor:** Poniard Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2007-04
- **Primary completion:** 2009-05
- **Final completion:** —
- **Target enrollment:** 399 (ESTIMATED)
- **Last updated:** 2009-04-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00465491

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00465491, "Study of Picoplatin Efficacy After Relapse". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00465491. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*